|
Atomistry » Bromine » PDB 4kvh-4my6 » 4lqm | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Bromine » PDB 4kvh-4my6 » 4lqm » |
Bromine in PDB 4lqm: Egfr L858R in Complex with PD168393Enzymatic activity of Egfr L858R in Complex with PD168393
All present enzymatic activity of Egfr L858R in Complex with PD168393:
2.7.10.1; Protein crystallography data
The structure of Egfr L858R in Complex with PD168393, PDB code: 4lqm
was solved by
C.H.Yun,
M.J.Eck,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 4lqm:
The structure of Egfr L858R in Complex with PD168393 also contains other interesting chemical elements:
Bromine Binding Sites:
The binding sites of Bromine atom in the Egfr L858R in Complex with PD168393
(pdb code 4lqm). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Egfr L858R in Complex with PD168393, PDB code: 4lqm: Bromine binding site 1 out of 1 in 4lqmGo back to![]() ![]()
Bromine binding site 1 out
of 1 in the Egfr L858R in Complex with PD168393
![]() Mono view ![]() Stereo pair view
Reference:
H.Yasuda,
E.Park,
C.H.Yun,
N.J.Sng,
A.R.Lucena-Araujo,
W.L.Yeo,
M.S.Huberman,
D.W.Cohen,
S.Nakayama,
K.Ishioka,
N.Yamaguchi,
M.Hanna,
G.R.Oxnard,
C.S.Lathan,
T.Moran,
L.V.Sequist,
J.E.Chaft,
G.J.Riely,
M.E.Arcila,
R.A.Soo,
M.Meyerson,
M.J.Eck,
S.S.Kobayashi,
D.B.Costa.
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (Egfr) Exon 20 Insertion Mutations in Lung Cancer. Sci Transl Med V. 5 RA177 2013.
Page generated: Mon Jul 7 07:02:29 2025
ISSN: ISSN 1946-6234 PubMed: 24353160 DOI: 10.1126/SCITRANSLMED.3007205 |
Last articlesFe in 2YXOFe in 2YRS Fe in 2YXC Fe in 2YNM Fe in 2YVJ Fe in 2YP1 Fe in 2YU2 Fe in 2YU1 Fe in 2YQB Fe in 2YOO |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |